Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IGF-1 in Phelan-McDermid Syndrome
NCT01525901Phase 2Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Feb 2012
- Primary completion
- Aug 2016
- Countries
- 1
01
Overview
A Phase 2 trial of mecasermin in Phelan-McDermid syndrome (PMS), sponsored by Icahn School of Medicine at Mount Sinai. Started Feb 2012; status: completed.
02
Drugs
mecasermin
03
Conditions
Phelan-McDermid syndrome (PMS)
Beyond the preview
Go deeper on NCT01525901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01525901.